Abstract
BackgroundThe Venezuelan equine encephalitis (VEE) virus replicon system was used to produce virus-like replicon particles (VRP) packaged with a number of different VEE-derived glycoprotein (GP) coats. The GP coat is believed to be responsible for the cellular tropism noted for VRP and it is possible that different VEE GP coats may have different affinities for cells. We examined VRP packaged in four different VEE GP coats for their ability to infect cells in vitro and to induce both humoral and cellular immune responses in vivo.Methodology/Principal FindingsThe VRP preparations were characterized to determine both infectious units (IU) and genome equivalents (GE) prior to in vivo analysis. VRP packaged with different VEE GP coats demonstrated widely varying GE/IU ratios based on Vero cell infectivity. BALB/c mice were immunized with the different VRP based on equal GE titers and the humoral and cellular responses to the expressed HIV gag gene measured. The magnitude of the immune responses measured in mice revealed small but significant differences between different GP coats when immunization was based on GE titers.Conclusions/SignificanceWe suggest that care should be taken when alternative coat proteins are used to package vector-based systems as the titers determined by cell culture infection may not represent accurate particle numbers and in turn may not accurately represent actual in vivo dose.
Highlights
Venezuelan equine encephalitis (VEE) virus is a member of the Togaviridae family within the Alphavirus genus
Infectious titers were determined for each preparation of virus-like replicon particles (VRP) on Vero cells and are referred to as infectious units (IU)
VRP have been shown to induce a broad array of immune responses to the foreign gene product expressed by the replicon, including cytotoxic T lymphocytes (CTL), lymphoproliferative responses and neutralizing antibodies
Summary
Venezuelan equine encephalitis (VEE) virus is a member of the Togaviridae family within the Alphavirus genus. A number of live attenuated VEE virus variants have been described [2,3,4,5,6,7] One of these attenuated VEE viruses (V3014) was used to generate a replicon system that has been used as a vaccine vector to express a wide array of genes [8,9]. The replicon RNA can be packaged into virus-like replicon particles (VRP) by supplying the structural protein genes of VEE in trans [8]. The Venezuelan equine encephalitis (VEE) virus replicon system was used to produce virus-like replicon particles (VRP) packaged with a number of different VEE-derived glycoprotein (GP) coats. We examined VRP packaged in four different VEE GP coats for their ability to infect cells in vitro and to induce both humoral and cellular immune responses in vivo
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.